CAS: 1421-14-3; Propyl 2-[4-[2-(Diethylamino)-2-Oxoethoxy]-3-Methoxyphenyl]Acetate
- 英文名称Propyl 2-[4-[2-(Diethylamino)-2-Oxoethoxy]-3-Methoxyphenyl]Acetate
- 中文名称丙泮尼地
- IUPAC名称propyl 2-(4-(2-(diethylamino)-2-oxoethoxy)-3-methoxyphenyl)acetate
- 其它别名Aceticacid, [4-[(diethylcarbamoyl)methoxy]-3-methoxyphenyl]-, propyl ester (7CI,8CI); Epontol; Fabantol; Fabontal; Propanidid; Propanidide; Propantan; Propyl4-(N,N-diethylcarbamidomethoxy)-3-methoxy-phenylacetate; Propyl[4-[(diethylcarbamoyl)methoxy]-3-methoxyphenyl]acetate; Sombrevin; [4-[(Diethylcarbamoyl)methoxy]-3-methoxyphenyl]acetic acid propyl ester
- CAS编号1421-14-3
- EINECS号:215-822-7
- FDA UNII编号:AO82L471NS
- 分子式:C18H27NO5分子量:337.41
- 产品CID: 644864
- 产品分类原料药 → 麻醉剂 → 全身麻醉药
物理性质
MSDS等安全信息
上下游产品
Propyl-2-(4-hydroxy-3-methoxy-phenyl)acetate 2-Chloro-N,N-diethylacetamide合成工艺路线路线简述
海关参考信息
- 2902600000-乙苯
2905121000-正丙醇
2907210001-间苯二酚
2909110000-乙醚 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2014315720-A1
优先权日:2012-10-24
标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
发明人：FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
权利人:CELANESE ACETATE LLC
摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: Čižmáriková R, Habala L, Markulia M. General intravenous anesthetics - pharmacodynamics, pharmacokinetics and chiral properties. Ceska Slov Farm. 2023 Fall;72(4):155-164. English.
82:129165. doi: 10.1016/j.bmcl.2023.129165. Epub 2023 Jan 31.
57:128497. doi: 10.1016/j.bmcl.2021.128497. Epub 2021 Dec 8. 89(S1):49-53. English. doi: 10.24875/CIRU.20001100. 103(1-2):10-16. doi: 10.1159/000493753. Epub 2018 Oct 17. 36(15):3926-3937. doi: 10.1080/07391102.2017.1403959. Epub 2017 Nov 29.
合成参考文献
摘要:Cox J, Robinson DJ. Anaesthesia at depth. Br J Hosp Med. 1980 Feb;23(2):144, 147, 150–1.
摘要:Pflüger H. [Raised cerebrospinal fluid pressure by intravenous administration of anesthetics]. Fortschr Med. 1980 Jan 10;98(1):9–11.
参考文献:10.1042/bj2330259
摘要:Kirkness EF, Turner AJ. The gamma-aminobutyrate/benzodiazepine receptor from pig brain. Enhancement of gamma-aminobutyrate-receptor binding by the anaesthetic propanidid. Biochem J. 1986 Jan 01;233(1):259–64.
参考文献:10.1007/978-1-4684-3288-6_33
摘要:Erdmann W, Kunke S. Changes of oxygen supply to the tissue following intravenous application of anesthetic drugs. Adv Exp Med Biol. 1973;37A():261–9. doi: 10.1007/978-1-4684-3288-6_33.
摘要:Alabau Lacomba A. [Use of Epontal in daily practice]. Rev Esp Estomatol. 1972 Jan;20(1):33–42.
📝 需求与反馈
尽可能描述清楚需求与问题信息
